Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2015 1
2016 1
2017 4
2018 2
2019 3
2020 2
2021 4
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Lower fluorodeoxyglucose positron emission tomography maximum standardized uptake value may show a better response to stereotactic body radiotherapy of adrenals in oligometastatic disease.
Zhelev K, Mihaylova-Hristov M, Conev N, Cholakova M, Korabova B, Petrov I, Georgieva N, Nedev N, Mihaylova I, Petrova M, Zahariev Z, Donev I. Zhelev K, et al. Among authors: donev i. Contemp Oncol (Pozn). 2023;27(4):263-268. doi: 10.5114/wo.2023.135288. Epub 2024 Feb 8. Contemp Oncol (Pozn). 2023. PMID: 38405207 Free PMC article.
Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospective Chart Review Study (REFLECT).
Janžič U, Turnšek N, Dediu M, Donev IS, Lupu R, Teodorescu G, Ciuleanu TE, Pluzanski A. Janžič U, et al. Among authors: donev is. Curr Oncol. 2022 Aug 17;29(8):5833-5845. doi: 10.3390/curroncol29080460. Curr Oncol. 2022. PMID: 36005198 Free PMC article.
Impact of travel burden on clinical outcomes in lung cancer.
Stoyanov DS, Conev NV, Donev IS, Tonev ID, Panayotova TV, Dimitrova-Gospodinova EG. Stoyanov DS, et al. Among authors: donev is. Support Care Cancer. 2022 Jun;30(6):5381-5387. doi: 10.1007/s00520-022-06978-8. Epub 2022 Mar 15. Support Care Cancer. 2022. PMID: 35288785
Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT).
Addeo A, Hochmair M, Janzic U, Dudnik E, Charpidou A, Płużański A, Ciuleanu T, Donev IS, Elbaz J, Aarøe J, Ott R, Peled N. Addeo A, et al. Among authors: donev is. Ther Adv Med Oncol. 2021 Nov 29;13:17588359211059874. doi: 10.1177/17588359211059874. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 35173817 Free PMC article.
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer.
Petrova MP, Eneva MI, Arabadjiev JI, Conev NV, Dimitrova EG, Koynov KD, Karanikolova TS, Valev SS, Gencheva RB, Zhbantov GA, Ivanova AI, Sarbianova II, Timcheva CV, Donev IS. Petrova MP, et al. Among authors: donev is. Biosci Trends. 2020 Mar 16;14(1):48-55. doi: 10.5582/bst.2019.01279. Epub 2020 Feb 4. Biosci Trends. 2020. PMID: 32023563 Free article.
24 results